Profitability
This table shows how Spectral AI compares to its competitors in terms of net margins, return on equity, and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Spectral AI | -89.85% | N/A | -104.64% |
| Competitors | -578.37% | -140.27% | -25.88% |
Ownership
67.1% of Spectral AI’s shares are owned by institutional investors, compared to 47.4% in the surgical and medical instruments sector. Additionally, 56.7% of shares are held by insiders, while the average is just 15.9% for the sector. This strong institutional ownership suggests confidence in Spectral AI’s long-term growth.
Volatility & Risk
Spectral AI has a beta of 0.56, meaning it’s 44% less volatile than the S&P 500. Its peers have an average beta of 0.53, indicating they’re also less volatile.
Analyst Ratings
Here’s a summary of recent analyst ratings for Spectral AI and its competitors:
| Sell | Hold | Buy | Strong Buy | Rating Score | |
| Spectral AI | 0 | 0 | 3 | 1 | 3.25 |
| Competitors | 1663 | 4406 | 8446 | 251 | 2.49 |
Spectral AI has a target price of $4.50, indicating a potential increase of 265.85%, compared to 17.84% for competitors. Analysts view Spectral AI more favorably due to its higher ratings and upside potential.
Valuation & Earnings
This table compares revenue, earnings per share (EPS), and valuation:
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| Spectral AI | $18.06 million | -$20.85 million | -0.92 |
| Competitors | $870.57 million | $47.37 million | -1.16 |
Competitors have higher revenue and earnings, and Spectral AI’s higher price-to-earnings ratio suggests it is more expensive compared to its peers.
Summary
Spectral AI outperforms its competitors in 10 out of 13 factors compared.
Company Profile
Spectral AI, Inc. develops AI-based medical diagnostics in the U.S., aimed at improving treatment for burn patients and those with diabetic foot ulcers. Key products include the DeepView System for wound assessment and the portable DeepView SnapShot M diagnostic tool. The company is based in Dallas, Texas.
Receive Daily News & Ratings for Spectral AI – Enter your email to get a daily summary of news and analyst ratings for Spectral AI and other companies with MarketBeat.com’s FREE daily newsletter.
`
